Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice.


Journal

Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422

Informations de publication

Date de publication:
02 2019
Historique:
received: 11 03 2018
revised: 21 09 2018
accepted: 07 11 2018
pubmed: 14 11 2018
medline: 14 5 2019
entrez: 14 11 2018
Statut: ppublish

Résumé

Poorly managed gestational diabetes can lead to severe complications for mother and child including fetal overgrowth, neonatal hypoglycemia and increased autism risk. Use of metformin to control it is relatively new and promising. Yet safety concerns regarding gestational metformin use remain, as its long-term effects in offspring are unclear. In light of beneficial findings with metformin for adult mouse social behavior, we hypothesized gestational metformin treatment might also promote offspring sociability. To test this, metformin was administered to non-diabetic, lean C57BL/6 J female mice at mating, with treatment discontinued at birth or wean. Male offspring exposed to metformin through birth lost social interaction preference relative to controls by time in chambers, but not by sniffing measures. Further, prenatal metformin exposure appeared to enhance social novelty preference only in females. However due to unbalanced litters and lack of statistical power, firm establishment of any sex-dependency of metformin's effects on sociability was not possible. Since organic cation transporter 3 (OCT3) transports metformin and is dense in placenta, social preferences of OCT3 knock-out males were measured. Relative to wild-type, OCT3 knock-outs had reduced interaction preference. Our data indicate gestational metformin exposure under non-diabetic conditions, or lack of OCT3, can impair social behavior in male C57BL6/J mice. Since OCT3 transports serotonin and tryptophan, impaired placental OCT3 function is one common mechanism that could persistently impact central serotonin systems and social behavior. Yet no gross alterations in serotonergic function were evident by measure of serotonin transporter density in OCT3, or serotonin turnover in metformin-exposed offspring brains. Mechanisms underlying the behavioral outcomes, and if with gestational diabetes the same would occur, remain unclear. Metformin's impacts on placental transporters and serotonin metabolism or AMPK activity in fetal brain need further investigation to clarify benefits and risks to offspring sociability from use of metformin to treat gestational diabetes.

Identifiants

pubmed: 30423430
pii: S1043-6618(18)30103-8
doi: 10.1016/j.phrs.2018.11.013
pmc: PMC6388691
mid: NIHMS1513010
pii:
doi:

Substances chimiques

Hypoglycemic Agents 0
Octamer Transcription Factor-3 0
Pou5f1 protein, mouse 0
Serotonin 333DO1RDJY
Metformin 9100L32L2N

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-32

Subventions

Organisme : NIA NIH HHS
ID : T32 AG021890
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH093320
Pays : United States
Organisme : NIGMS NIH HHS
ID : R25 GM097632
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH106978
Pays : United States
Organisme : NICHD NIH HHS
ID : R21 HD081261
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Références

J Clin Endocrinol Metab. 2018 Feb 1;103(2):740-747
pubmed: 29165598
Pediatrics. 2012 May;129(5):e1121-8
pubmed: 22492772
Drug Saf. 2015 Jan;38(1):65-78
pubmed: 25542297
JAMA. 2015 Apr 14;313(14):1425-34
pubmed: 25871668
Placenta. 2016 Jun;42:74-83
pubmed: 27238716
N Engl J Med. 2005 Jun 16;352(24):2477-86
pubmed: 15951574
BMJ. 2018 Jun 25;361:k2477
pubmed: 29941493
J Neurochem. 2008 Aug;106(3):1471-82
pubmed: 18513366
Drug Metab Dispos. 2010 May;38(5):833-40
pubmed: 20118196
Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9983-8
pubmed: 24961373
Proc Natl Acad Sci U S A. 2009 May 12;106(19):8043-8
pubmed: 19416912
J Biol Chem. 2012 Jun 8;287(24):20088-99
pubmed: 22511782
Curr Protoc Neurosci. 2011 Jul;Chapter 8:Unit 8.26
pubmed: 21732314
Br J Clin Pharmacol. 2015 Nov;80(5):1224-34
pubmed: 25925501
Diabetes Metab Res Rev. 2014 Jan;30(1):23-30
pubmed: 23983188
Nat Med. 2017 Jun;23(6):674-677
pubmed: 28504725
Teratology. 1994 Apr;49(4):260-6
pubmed: 8073364
J Matern Fetal Neonatal Med. 2002 Dec;12(6):376-83
pubmed: 12683647
Biochem Biophys Res Commun. 2011 Jan 28;404(4):1010-5
pubmed: 21187065
Neuroscience. 2016 May 3;321:24-41
pubmed: 26577932
Pharmacol Ther. 2011 Jul;131(1):61-79
pubmed: 21447358
Diabetologia. 2013 Sep;56(9):1898-906
pubmed: 23835523
Drug Metab Pharmacokinet. 2010;25(4):392-7
pubmed: 20814161
Diabetes Res Clin Pract. 2012 Dec;98(3):422-9
pubmed: 23068960
Mol Pharmacol. 2018 Oct;94(4):1125-1131
pubmed: 30012584
Diabetes Care. 2006 Feb;29(2):485-6
pubmed: 16443923
Clin Pharmacokinet. 2011 Feb;50(2):81-98
pubmed: 21241070
J Biol Chem. 1998 Jun 26;273(26):15971-9
pubmed: 9632645
Biol Reprod. 2017 Feb 1;96(2):435-445
pubmed: 28203773
Clin Pharmacol Ther. 2018 May;103(5):758-760
pubmed: 29193038
Front Cell Neurosci. 2013 Apr 23;7:47
pubmed: 23630464
BMJ Open Diabetes Res Care. 2018 Apr 13;6(1):e000456
pubmed: 29682291
Nat Rev Neurosci. 2003 Dec;4(12):1002-12
pubmed: 14618156
PLoS One. 2012;7(5):e36637
pubmed: 22590580
Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):329-34
pubmed: 17182745
J Obstet Gynaecol Res. 2008 Feb;34(1):1-6
pubmed: 18226121
J Pharm Sci. 2011 Sep;100(9):3875-83
pubmed: 21523786
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Reprod Med Biol. 2017 Apr 04;16(2):179-187
pubmed: 29259467
Neuropsychopharmacology. 2018 Nov;43(12):2408-2417
pubmed: 29773909
Diabet Med. 2009 Aug;26(8):798-802
pubmed: 19709150
Autism Res. 2017 Sep;10(9):1544-1546
pubmed: 28383189
J Neural Transm (Vienna). 2009 Jun;116(6):689-97
pubmed: 19280114
EBioMedicine. 2018 May;31:143-149
pubmed: 29709497
J Pharm Sci. 2014 Oct;103(10):3342-8
pubmed: 25175747
N Engl J Med. 2008 May 8;358(19):2003-15
pubmed: 18463376
Fertil Steril. 2005 May;83(5):1575-8
pubmed: 15866611
Curr Diab Rep. 2012 Feb;12(1):33-42
pubmed: 22139557
J Clin Endocrinol Metab. 2018 Apr 1;103(4):1612-1621
pubmed: 29490031
Neuroscience. 2010 Dec 29;171(4):1197-208
pubmed: 20888890
J Pharmacol Exp Ther. 2004 Mar;308(3):949-56
pubmed: 14718608
Diabetes Care. 2011 Oct;34(10):2279-84
pubmed: 21949222
Brain Res. 1985 Jun 24;337(1):99-108
pubmed: 4005611
J Pharmacol Exp Ther. 2010 Dec;335(3):743-53
pubmed: 20858707
Mol Cell Biol. 2001 Jul;21(13):4188-96
pubmed: 11390648
PLoS One. 2014 Dec 26;9(12):e115778
pubmed: 25541979
Mol Pharmacol. 2015 Jul;88(1):75-83
pubmed: 25920679
Neuropsychopharmacology. 2012 Jan;37(1):299-300
pubmed: 22157865
Nature. 2011 Apr 21;472(7343):347-50
pubmed: 21512572
J Biol Chem. 2014 Sep 26;289(39):27055-64
pubmed: 25107910
Diabetes Res Clin Pract. 2016 Sep;119:106-17
pubmed: 27497146
Pharmacogenet Genomics. 2010 Nov;20(11):687-99
pubmed: 20859243
Drug Metab Dispos. 2013 Dec;41(12):2225-32
pubmed: 24101703
Diabetes. 2015 Jul;64(7):2526-36
pubmed: 25720389
Reprod Toxicol. 2017 Dec;74:48-58
pubmed: 28867217
Nat Med. 2010 Jul;16(7):804-8
pubmed: 20581837
Reprod Fertil Dev. 2014 Dec;27(1):31-9
pubmed: 25472042
J Pharmacokinet Pharmacodyn. 2015 Oct;42(5):463-75
pubmed: 26335661
J Pharm Pharmacol. 2016 Sep;68(9):1160-9
pubmed: 27350110
Fertil Steril. 2001 Nov;76(5):1078-9
pubmed: 11704144
Placenta. 2005 Jul;26(6):498-504
pubmed: 15950064
Nat Rev Drug Discov. 2015 Jan;14(1):29-44
pubmed: 25475361
Pharm Res. 2007 Jul;24(7):1227-51
pubmed: 17473959
Medicine (Baltimore). 2017 May;96(18):e6696
pubmed: 28471964
Am J Obstet Gynecol. 2012 Apr;206(4):314.e1-9
pubmed: 22464070
J Neurosci. 2001 Aug 15;21(16):6348-61
pubmed: 11487658
Placenta. 2004 Jul;25(6):518-29
pubmed: 15135235
Pediatrics. 2016 Feb;137(2):e20152206
pubmed: 26826214
Exp Ther Med. 2016 Sep;12(3):1293-1298
pubmed: 27602061
Clin Pharmacokinet. 2016 Apr;55(4):439-59
pubmed: 26330026
Aquat Toxicol. 2018 Feb;195:33-40
pubmed: 29248761
Diabetes Obes Metab. 2017 Jun;19(6):765-772
pubmed: 28127850

Auteurs

Valentina R Garbarino (VR)

Center for Biomedical Neuroscience, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., Physiology-MC 7756, San Antonio, TX, 78229, USA. Electronic address: garbarino@livemail.uthscsa.edu.

Taylor A Santos (TA)

Center for Biomedical Neuroscience, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., Physiology-MC 7756, San Antonio, TX, 78229, USA. Electronic address: tas160930@utdallas.edu.

Anastassia R Nelson (AR)

Center for Biomedical Neuroscience, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., Physiology-MC 7756, San Antonio, TX, 78229, USA. Electronic address: nelsonar@uthscsa.edu.

Wynne Q Zhang (WQ)

Center for Biomedical Neuroscience, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., Physiology-MC 7756, San Antonio, TX, 78229, USA; Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA. Electronic address: wqzhang@bcm.edu.

Corey M Smolik (CM)

Center for Biomedical Neuroscience, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., Physiology-MC 7756, San Antonio, TX, 78229, USA; Texas Tech University Health Science Center, 3601 4th Street, Lubbock, TX 79430, USA. Electronic address: corey.smolik@ttuhsc.edu.

Martin A Javors (MA)

Center for Biomedical Neuroscience, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., Physiology-MC 7756, San Antonio, TX, 78229, USA. Electronic address: javors@uthscsa.edu.

Lynette C Daws (LC)

Center for Biomedical Neuroscience, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., Physiology-MC 7756, San Antonio, TX, 78229, USA. Electronic address: daws@uthscsa.edu.

Georgianna G Gould (GG)

Center for Biomedical Neuroscience, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., Physiology-MC 7756, San Antonio, TX, 78229, USA. Electronic address: gouldg@uthscsa.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH